6978 — Immunotech Biopharm Share News
0.000.00%
Last trade - 00:00- HK$225.39m
- HK$621.13m
Brief: Immunotech Biopharm Says Clinical Approval For Denocabtagene Ciloleucel Injection
Brief: Immunotech Biopharm Says Receipt Of Acceptance Notice For IND Application
Brief: Immunotech Biopharm Says Trading In Shares Of Co Halted From 31 Oct
Brief: Immunotech Biopharm Says Chairman Acquired A Total Of 13.7 Mln Ordinary Shares
Brief: Immunotech Biopharm Says HY Loss Attributable RMB140.3 Mln
Brief: Immunotech Biopharm Says Unit Entered Into A Joint Venture Agreement With Shanghai Nky Precision Medical
Brief: Immunotech Biopharm & China Resources Pharmaceutical Enter Strategic Cooperation Framework Deal
Brief: Immunotech Biopharm Posts HY Loss Before Tax RMB147.6 Million
Brief: China Resources Pharma's Long Position In Immunotech Biopharm Rises To 10% - HKEX Filing
HK-listed Immunotech hits near 6-week high as China Resources Pharma buys stake
Brief: China Resources Pharmaceutical Group Says Unit To Buy 10.0% Stake In Immunotech Biopharm
Brief: Immunotech Biopharm Says Entered Construction Agreement
Brief: Immunotech Biopharm Says FY Loss And Total Comprehensive Expenses RMB439.0 Mln
Brief: Immunotech Biopharm Says Unit Entered LP Agreement With Three Entities
Brief: Immunotech Biopharm Says Entered Into License Agreement With T-Cure
Brief: Immunotech Biopharm Enters Subscription Deal With Tasly Bioscience Fund For HK$156.8 Mln
Brief: Immunotech Biopharm Announces IND Application Approval For CAR-T-19 Injection By CDE
E-cigarette maker Smoore, Ocumension more than double on HK debut, others jump